AI assistant
Sending…
Iterum Therapeutics plc — Director's Dealing 2018
Sep 6, 2018
34796_dirs_2018-09-06_9826e5c4-bce6-4b2e-8731-1ce976f61fb3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Iterum Therapeutics plc (ITRM)
CIK: 0001659323
Period of Report: 2018-09-04
Reporting Person: Dunne Michael W. (Chief Scientific Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-09-04 | Ordinary Shares | P | 500 | $10.00 | Acquired | 147958 | Direct |
More from Iterum Therapeutics plc
Delisting Announcement
2026
Mar 31
Regulatory Filings
2026
Mar 27
Regulatory Filings
2026
Mar 3
Delisting Announcement
2026
Mar 2
Declaration of Voting Results & Voting Rights Announcements
2026
Feb 18
Proxy Solicitation & Information Statement
2026
Jan 2
Proxy Solicitation & Information Statement
2025
Dec 23
Delisting Announcement
2025
Dec 12
Director's Dealing
2025
Nov 20
Interim / Quarterly Report
2025
Nov 14